Use of Glucocorticoids and Risk of Venous Thromboembolism A Nationwide Population-Based Case-Control Study

被引:325
|
作者
Johannesdottir, Sigrun A. [1 ]
Horvath-Puho, Erzsebet [1 ]
Dekkers, Olaf M. [3 ,4 ]
Cannegieter, Suzanne C. [3 ]
Jorgensen, Jens Otto L. [2 ]
Ehrenstein, Vera [1 ]
Vandenbroucke, Jan P. [3 ]
Pedersen, Lars [1 ]
Sorensen, Henrik Toft [1 ]
机构
[1] Aarhus Univ Hosp, Dept Clin Epidemiol, Inst Clin Med, DK-8200 Aarhus N, Denmark
[2] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8200 Aarhus N, Denmark
[3] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Dept Clin Endocrinol & Metab, Leiden, Netherlands
关键词
DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; REPLACEMENT THERAPY; CUSHINGS-SYNDROME; DISORDERS; DATABASE; DISEASE; SYSTEM; COHORT;
D O I
10.1001/jamainternmed.2013.122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance: Excess endogenous cortisol has been linked to venous thromboembolism (VTE) risk, but whether this relationship applies to exogenous glucocorticoids remains uncertain. Because the prevalence of glucocorticoid use and the incidence of VTE are high, an increased risk of VTE associated with glucocorticoid use would have important implications. Background: To examine the association between glucocorticoid use and VTE. Design: Population-based case-control study using nationwide databases. Setting: Denmark (population 5.6 million). Participants: We identified 38 765 VTE cases diagnosed from January 1, 2005, through December 31, 2011, and 387 650 population controls included through risk-set sampling and matched by birth year and sex. The VTE diagnosis date for the case was the index date for cases and matched controls. Exposure: We classified individuals who filled their most recent glucocorticoid prescription 90 days or less, 91 to 365 days, and more than 365 days before the index date as present, recent, and former users, respectively. Present users were subdivided into new (first-ever prescription 90 days or less before the index date) and continuing users (others). Main Outcomes and Measures: We used conditional logistic regression adjusted for VTE risk factors to estimate incidence rate ratios (IRRs) and 95% CIs for glucocorticoid users vs nonusers. Results: Systemic glucocorticoids increased VTE risk among present (adjusted IRR, 2.31; 95% CI, 2.18-2.45), new (3.06; 2.77-3.38), continuing (2.02; 1.88-2.17), and recent (1.18; 1.10-1.26) users but not among former users (0.94; 0.90-0.99). The adjusted IRR increased from 1.00 (95% CI, 0.93-1.07) for a prednisolone-equivalent cumulative dose of 10 mg or less to 1.98 (1.78-2.20) for more than 1000 to 2000 mg, and to 1.60 (1.49-1.71) for doses higher than 2000 mg. New use of inhaled (adjusted IRR, 2.21; 95% CI, 1.72-2.86) and intestinalacting (2.17; 1.27-3.71) glucocorticoids also increased VTE risk. Conclusions and Relevance: The risk of VTE is increased among glucocorticoid users. Although residual confounding may partly explain this finding, we consider a biological mechanism likely because the association followed a clear temporal gradient, persisted after adjustment for indicators of severity of underlying disease, and existed also for noninflammatory conditions. Hence, our observations merit clinical attention.
引用
收藏
页码:743 / 752
页数:10
相关论文
共 50 条
  • [21] Racial and ethnic differences in the risk of postpartum venous thromboembolism: a population-based, case-control study
    Blondon, M.
    Harrington, L. B.
    Righini, M.
    Boehlen, F.
    Bounameaux, H.
    Smith, N. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (12) : 2002 - 2009
  • [22] Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study
    Barsoum, Michel K.
    Heit, John A.
    Ashrani, Aneel A.
    Leibson, Cynthia L.
    Petterson, Tanya M.
    Bailey, Kent R.
    THROMBOSIS RESEARCH, 2010, 126 (05) : 373 - 378
  • [23] Novel risk factors for venous thromboembolism (VTE): A population-based case-control study.
    Heit, JA
    Farmer, SA
    Petterson, TM
    Bailey, KR
    Melton, LJ
    BLOOD, 2005, 106 (11) : 463A - 463A
  • [24] Hormone replacement therapy with estradiol and risk of venous thromboembolism - A population-based case-control study
    Holbraaten, E
    Abdelnoor, M
    Sandset, PM
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (04) : 1218 - 1221
  • [25] Is Diabetes Mellitus an Independent Risk Factor for Venous Thromboembolism? A Population-Based Case-Control Study
    Heit, John A.
    Leibson, Cynthia L.
    Ashrani, Aneel A.
    Petterson, Tanya M.
    Bailey, Kent R.
    Melton, L. Joseph, III
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (09) : 1399 - 1405
  • [26] Use of Nsaids Correlates with the Risk of Venous Thromboembolism in Knee OA Patients: A UK Population-Based Case-Control Study
    Lee, Taeyeon
    Lu, Na
    Felson, David T.
    Choi, Hyon K.
    Dalal, Deepan S.
    Zhang, Yuqing
    Dubreuil, Maureen
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [27] Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study
    Fournier, Jean-Pascal
    Duijnhoven, Ruben G.
    Renoux, Christel
    Dell'Aniello, Sophie
    Klungel, Olaf H.
    Suissa, Samy
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (09): : 1023 - 1026
  • [28] Testosterone treatment and risk of venous thromboembolism: population based case-control study
    Martinez, Carlos
    Suissa, Samy
    Rietbrock, Stephan
    Katholing, Anja
    Freedman, Ben
    Cohen, Alexander T.
    Handelsman, David J.
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 355
  • [29] Risk of venous thromboembolism in elderly patients with vertebral compression fracture A population-based case-control study
    Huang, Ching-Hui
    Wang, Wei-Hsun
    Kor, Chew-Teng
    Hsiao, Ching-Hua
    Chang, Chia-Chu
    MEDICINE, 2020, 99 (18) : E20072
  • [30] Thrombomodulin mutations as potential risk factors for venous thromboembolism: A population-based case-control study.
    Heit, JA
    Allred, CC
    Lokken, TG
    Ye, H
    Owen, WG
    Thibodeau, SN
    Petterson, TM
    O'Fallon, WM
    Melton, LJ
    BLOOD, 2001, 98 (11) : 90B - 90B